The Catatonia Quick Screen (CQS): A Rapid Screening Tool for Catatonia in Adult and Pediatric Populations
- 6 May 2025
- journal article
- research article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 152 (5) , 341-349
Abstract
Introduction: Catatonia is a potentially lethal and frequently underdiagnosed neuropsychiatric disorder marked by significant disturbances in motor, cognitive, and affective functioning. To enhance clinical detection of catatonia, this study aimed to develop and independently validate a rapid, sensitive Catatonia Quick Screen (CQS) using a reduced set of catatonic signs to facilitate screening in both adult and pediatric patients.Methods: Training data were derived from two retrospective cohorts totaling 446 patients (254 adults, 192 children) who screened positive for catatonia using the Bush Francis Catatonia Screening Instrument (BFCSI). The sensitivity of every potential combination of BFCSI signs was calculated from these data, with sensitivity defined as the proportion of patients identified by each combination of signs relative to the full BFCSI. The CQS was developed by selecting the combination of signs from the BFCSI that offered high sensitivity, ease of assessment by non‐expert providers, and relevance to diverse catatonia presentations. The CQS was then validated in an independent 1456 patient cohort.Results: Using only four of the full BFCSI's 14 signs—excitement, mutism, staring, and posturing—yielded a sensitivity of 97% (95% CI: 95%–98%) relative to the BFCSI across both pediatric and adult patients within the training data. The CQS showed only a modest decrease in sensitivity (91%; 95% CI: 90%–93%) relative to the BFCSI when tested on the independent 1456 patient validation cohort.Conclusion: The CQS provides an independently validated, high sensitivity, rapid, and easy to use screening alternative to the BFCSI, potentially improving early detection of catatonia in clinical settings. A positive CQS should lead to a more detailed and definitive assessment for catatonia. Future prospective studies are necessary to determine the specificity of the CQS in diverse clinical populations.Keywords
All Related Versions
Funding Information
- National Institute of Mental Health (T32MH112485, R01MH135028)
- National Institute for Health and Care Research
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (1P50HD103537)
This publication has 44 references indexed in Scilit:
- Longitudinal Symptom Burden and Pharmacologic Management of Catatonia in Autism With Intellectual Disability: An Observational StudyAutism Research, 2025
- Screening for Depression and Suicide Risk in AdultsJAMA, 2023
- The State of the Catatonia Literature: Employing Bibliometric Analysis of Articles From 1965–2020 to Identify Current Research GapsJournal of the Academy of Consultation-Liaison Psychiatry, 2022
- The occurrence of catatonia diagnosis in acute care hospitals in the United States: A national inpatient sample analysisGeneral Hospital Psychiatry, 2022
- Accuracy of the PHQ-2 Alone and in Combination With the PHQ-9 for Screening to Detect Major DepressionJAMA, 2020
- On the pathophysiology and treatment of akinetic mutismNeuroscience & Biobehavioral Reviews, 2020
- Assessing catatonia using four different instruments: Inter-rater reliability and prevalence in inpatient clinical populationAsian Journal of Psychiatry, 2016
- The diagnostic criteria and structure of catatoniaSchizophrenia Research, 2015
- Association of adolescent catatonia with increased mortality and morbidity: Evidence from a prospective follow-up studySchizophrenia Research, 2009
- The bootstrap: A technique for data-driven statistics. Using computer-intensive analyses to explore experimental dataClinica Chimica Acta, 2005